Search results
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoFlamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC) PR Newswire ...
Enspectra receives breakthrough status for AI-powered skin imaging platform
Medical Device Network via Yahoo Finance· 2 days agoThe imaging platform is aimed at evaluating lesions indicative of basal cell carcinoma (BCC) and ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoSugemalimab is expected to become the first anti-PD-L1 monoclonal antibody (mAb) in the world approved in Europe for both first-line squamous and non-squamous< ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 15 hours agoThe companies are also testing the combo in patients with melanoma, non-small cell lung cancer,...
..., in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous ...
Digital Journal· 5 days ago"It is encouraging that IFx-2.0 demonstrated the ability to overcome resistance to ICI in 63% of patients with advanced MCC, even in patients who progressed on both anti-PD1 therapy followed ...
EMA CHMP supports CStone’s sugemalimab for metastatic NSCLC
Pharmaceutical Technology via Yahoo Finance· 5 days ago“The CHMP recommendation brings us closer to delivering this innovative treatment to European...
How to Spot Skin Cancer on the Scalp (Hint: Your Hair Stylist Can Help) + 4 Ways To Cut Your Risk
Woman's World via Yahoo News· 5 days agoBasal cell carcinoma may look like a pink or fleshy bump, while squamous cell carcinoma typically...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 4 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Replimune (REPL) Gains on Positive Data From Melanoma Study
Zacks via Yahoo Finance· 15 hours agoReplimune's (REPL) lead pipeline candidate RP1, in combination with Opdivo, leads to an overall...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via AOL· 4 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...